Noted for handling the full spectrum of issues within the healthcare and life sciences sectors, Bär & Karrer Ltd. stands out for handling supply chain and licensing issues, in addition to contentious reimbursement and compliance work. Markus Schott is well-known for his expertise in public procurement and administrative proceedings within the pharma and medical device spaces. Markus Wang leads the firm’s IP practice, often advising on drug distribution and promotion, on top of acting in major patent disputes. Commercial litigation expert Oliver M. Brupbacher is a key name for investigations. Djamila Batache and Christine Schweikard are key figures within the team known for their IP and regulatory expertise respectively. Claudia Götz Staehelin left the firm in March 2025.
Legal 500 redaktioneller Kommentar
- Profil
- Soziale Medien
Auszeichnungen
Mandantenzufriedenheit
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
'Markus Schott: expert in the pharmaceutical sector, very pragmatic, always available.'
‘Available partners and the team are very easy going and solution oriented. Pragmatic solutions and aware of clients' interests.’
‘It is Bär & Karrer's in-house experience in pharmaceutical law that sets it apart from other leading Swiss law firms. In my opinion, Bär & Karrer also has the largest and most specialised team of lawyers in the healthcare and life sciences sector in Switzerland.'
'I would like to highlight the young talent Christine Schweikard, who is a brilliant specialist. This means that Bär & Karrer is also very well positioned for the years to come.’
‘Oliver Brupbacher stands out as he used to work in-house before joining private practice, and he is bringing this in-house perspective to his work. He helps us gain a broad overview and understanding of the issues that we deal with, and helps us to dive deeper where we need to. He has a very commercial view, which makes it so much easier to translate his recommendations for our internal business people.’
'Great knowledge of the law and practical expertise, complemented by excellent forensic support.'
'You feel very, very well taken care of by them and can sort of rest easy during an investigation "crisis", knowing that they will take excellent care of you and fight tooth and nail for you if must be. 10 out of 10!'
Kernmandanten
- Moderna Switzerland GmbH
- Moderna, Inc.
- Novartis
- Pro Medicus AG
Highlight-Mandate
- Advising Moderna on various legal matters in connection with its business in Switzerland and abroad, including legal and regulatory advice related to the establishment of its supply chain for its COVID-19 vaccine.
- Advising Pro Medicus AG in connection with its contractual arrangements and the implementation of the Procura program, allowing health care professionals to partially retain rebate on drugs received from pharmaceutical companies under new integrity and transparency regulations.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Führende Associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Djamila Batache
Praxisleitung
Markus Schott; Markus Wang; Oliver M. Brupbacher
Weitere Kernanwält*innen
Christine Schweikard; Djamila Batache